[Induction of EIAV-specific cellular immune response by attenuated EIAV vaccine]

Area of Science:

• Veterinary immunology
• Viral immunology
• Equine immunology

Context:

• Equine infectious anemia virus (EIAV) poses a significant threat to equine health.
• Understanding the cellular immune mechanisms underlying protection against EIAV is crucial for vaccine development.
• Previous studies have explored various approaches to elicit protective immunity against EIAV.

Purpose:

• To investigate the cellular immune response generated by a DLV (attenuated) vaccine in horses against EIAV.
• To assess the efficacy of DLV immunization in inducing EIAV-specific cytotoxic T lymphocyte (CTL) activity and lymphocyte proliferation.

Summary:

• Horses immunized with DLV vaccine showed a 20% to 30% increase in EIAV-specific CTL lysis compared to controls (<5%).
• Lymphocyte proliferation assays indicated a stimulation index of 3 in DLV-immunized horses.
• These findings suggest that DLV immunization effectively primes cellular immunity against EIAV.

Impact:

• The study highlights the potential of DLV as a vaccine candidate for EIAV by demonstrating its ability to induce protective cellular immune responses.
• Results provide valuable insights into the cellular immune mechanisms contributing to protection against EIAV.
• This research could inform future strategies for developing more effective EIAV vaccines.